The NCCN has updated its bladder cancer guidelines to include FDA-approved ctDNA-based MRD testing for post-surgical risk assessment and adjuvant immunotherapy decisions in muscle-invasive bladder cancer.
The system uses routine blood draws to provide results in 17 minutes, offering an alternative to invasive diagnostic methods.
A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.
The FDA has granted Breakthrough Device Designation to Valar Labs’ Vesta Bladder Risk Stratify Dx, the first AI-powered digital pathology prognostic test for bladder cancer.
Agilent Technologies has partnered with OpenAI and Boston Consulting Group to accelerate artificial intelligence deployment in lab workflows, aiming to deliver faster scientific insights and advance intelligent instruments, software, and services.
Researchers identify molecular markers in saliva that could lead to new clinical tests for sleep loss.
Bio-Rad has expanded its TrailBlazer StarBright Dye Label Kits to 32 options, now available in Europe for flow cytometry and fluorescent western blot applications, according to the company.
The XR-Series features higher throughput and enhanced analytics to streamline daily laboratory operations.
Biomarkers in midlife adults without dementia may be linked to the earliest signs of waning cognition, researchers found.
The new triple quadrupole mass spectrometry system aims to increase sample throughput and simplify interference removal.
The new capability helps clinicians determine if a patient's infection will respond to gepotidacin before prescribing the treatment.
Guardant360 CDx can now identify patients eligible for zongertinib, the first targeted therapy approved as an initial treatment option for HER2-mutant advanced non-small cell lung cancer.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.